We are live on
!
Find out more
Mirae Asset Global Investments Portfolio holdings
AUM
$67.7B
1-Year Est. Return
57.61%
This Fund
S&P 500
This Quarter
Est. Return
+15.81%
1 Year Est. Return
+57.61%
3 Year Est. Return
+150.9%
5 Year Est. Return
+201.56%
10 Year Est. Return
+1,018.7%
AUM
$28.7B
AUM Growth
+$4.18B
(+17%)
Cap. Flow
-$12B
Cap. Flow
% of AUM
-41.89%
Top 10 Holdings %
Top 10 Hldgs %
36.41%
Holding
1,665
New
77
Increased
1,003
Reduced
447
Closed
86
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$63.9M |
| 2 |
iShares MBS ETF
MBB
|
+$57.4M |
| 3 |
PIMCO 25+ Year Zero Coupon US Treasury Index Exchange-Traded Fund
ZROZ
|
+$57.3M |
| 4 |
iShares S&P 100 ETF
OEF
|
+$54M |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$31.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$4.13B |
| 2 |
MakeMyTrip
MMYT
|
+$2.41B |
| 3 |
Trip.com Group
TCOM
|
+$770M |
| 4 |
Yum China
YUMC
|
+$508M |
| 5 |
Alibaba
BABA
|
+$477M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.56% |
| 2 | Communication Services | 9.63% |
| 3 | Consumer Discretionary | 9.36% |
| 4 | Healthcare | 6.11% |
| 5 | Financials | 5.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Tyra Biosciences
TYRA
$1.49B
| $19.7K | ﹤0.01% |
2,054
+361
| +21% | +$3.43K |
|
|
SEZL
1402
Sezzle
SEZL
$4.37B
| $19.4K | ﹤0.01% |
108
-3,660
| -97% | -$324K |
|
1403
Kura Oncology
KURA
$882M
| $19.3K | ﹤0.01% |
3,344
+642
| +24% | +$3.93K |
|
|
MESO
1404
Mesoblast
MESO
$2.18B
| $19.1K | ﹤0.01% |
1,755
+617
| +54% | +$6.91K |
|
|
DFTX
1405
Definium Therapeutics
DFTX
$5.9B
| $18.9K | ﹤0.01% |
2,919
+465
| +19% | +$3.06K |
|
|
AMED
1406
DELISTED
Amedisys
AMED
| $18.9K | ﹤0.01% |
192
-11
| -5% | -$1.04K |
|
|
DEA
1407
Easterly Government Properties
DEA
$1.16B
| $18.9K | ﹤0.01% |
850
-235
| -22% | -$5.13K |
|
|
PDM
1408
Piedmont Realty Trust
PDM
$1.19B
| $18.8K | ﹤0.01% |
2,577
-772
| -23% | -$5.33K |
|
1409
Zevra Therapeutics
ZVRA
$679M
| $18.6K | ﹤0.01% |
2,112
+326
| +18% | +$2.65K |
|
1410
Saia
SAIA
$10.1B
| $18.4K | ﹤0.01% |
67
+1
| +2% | +$285 |
|
|
ZK
1411
DELISTED
Zeekr
ZK
| $18.3K | ﹤0.01% |
717
+77
| +12% | +$1.9K |
|
1412
HUTCHMED
HCM
$2.13B
| $18K | ﹤0.01% |
1,198
+160
| +15% | +$2.34K |
|
1413
SIGA Technologies
SIGA
$206M
| $18K | ﹤0.01% |
2,760
+371
| +16% | +$2.23K |
|
|
AUTL
1414
Autolus Therapeutics
AUTL
$564M
| $17.7K | ﹤0.01% |
7,746
+1,956
| +34% | +$3.23K |
|
1415
Marathon Digital Holdings
MARA
$3.56B
| $17.5K | ﹤0.01% |
1,115
-11,708
| -91% | -$168K |
|
1416
Fortrea Holdings
FTRE
$1.74B
| $17.3K | ﹤0.01% |
3,496
+653
| +23% | +$3.51K |
|
1417
Cullinan Oncology
CGEM
$1.26B
| $17.2K | ﹤0.01% |
2,280
+306
| +16% | +$2.46K |
|
|
SNDK
1418
Sandisk
SNDK
$223B
| $16.6K | ﹤0.01% |
365
+79
| +28% | +$3.02K |
|
|
IRBT
1419
DELISTED
iRobot
IRBT
| $16.4K | ﹤0.01% |
5,254
+360
| +7% | +$996 |
|
1420
Gaotu Techedu
GOTU
$410M
| $16.2K | ﹤0.01% |
+4,500
| New | +$15.4K |
|
|
ORKA
1421
Oruka Therapeutics
ORKA
$7.11B
| $16.2K | ﹤0.01% |
1,446
+193
| +15% | +$2.01K |
|
1422
Precigen
PGEN
$2.32B
| $16.2K | ﹤0.01% |
11,403
+1,603
| +16% | +$2.28K |
|
1423
Core Scientific
CORZ
$6.36B
| $16.2K | ﹤0.01% |
948
-5,916
| -86% | -$59.2K |
|
|
RAPP
1424
Rapport Therapeutics
RAPP
$2.29B
| $16K | ﹤0.01% |
1,410
+144
| +11% | +$1.53K |
|
1425
Unity
U
$20.2B
| $16K | ﹤0.01% |
662
-89,404
| -99% | -$1.97M |
|
Similar funds
BC
Mirae Asset Global Investments's Q2 2025 Portfolio in Review
As of Q2 2025, Mirae Asset Global Investments held 1,665 positions worth $28.7B, up 17% from $24.5B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Mirae Asset Global Investments withdrew a net $12B in Q2 2025, closing 86 positions and reducing 447 holdings. Its most notable exit was iShares MSCI ACWI ETF, an estimated $19.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 31% a quarter earlier, followed by Communication Services and Consumer Discretionary.
Against the trend, Mirae Asset Global Investments opened a new position in iShares S&P 100 ETF worth $58.9M.
- Mirae Asset Global Investments's largest Q2 2025 buy was iShares S&P 100 ETF: 193,670 shares worth $58.9M.
- Mirae Asset Global Investments added most to State Street SPDR Portfolio S&P 500 ETF in Q2 2025, an estimated $63.9M increase.
- Mirae Asset Global Investments's biggest Q2 2025 reduction was Pinduoduo, cutting an estimated $4.13B.
- Mirae Asset Global Investments fully exited iShares MSCI ACWI ETF in Q2 2025, selling an estimated $19.3M.
- Mirae Asset Global Investments's ten largest holdings make up 36% of its $28.7B portfolio in Q2 2025.
- Mirae Asset Global Investments opened 77 new positions and closed 86 in Q2 2025.
- Mirae Asset Global Investments's portfolio value rose 17% quarter-over-quarter to $28.7B.
Based on Mirae Asset Global Investments's 13F filing for Q2 2025, filed 21 Jul 2025.